Company Number: 12796117

Analysis Date: 2025-07-20 12:03 UTC

Financial Health Assessment for AW Aromatics Limited (As of 31 March 2024)

---

1. Financial Health Score: D

This score reflects a company showing clear symptoms of financial distress, particularly around liquidity and solvency, despite being operational. The persistent negative net current assets and shareholders’ funds indicate financial strain, requiring urgent attention to avoid further deterioration.

---

2. Key Vital Signs and Interpretation

Metric	2024 Value	Interpretation
Current Assets	£1,300,592	Adequate short-term resources but heavily reliant on stock
Cash at Bank	£176,522	Low cash reserves relative to liabilities; liquidity concern
Debtors	£382,069	Moderate receivables; potential cash flow timing risk
Stock	£742,001	Very high inventory levels; risk of obsolescence or overstock
Current Liabilities	£1,533,206	Substantial short-term debts; pressure on working capital
Net Current Assets (Working Capital)	-£232,614	Negative working capital—a critical symptom of distress
Total Assets Less Current Liabilities	-£160,502	Negative net assets; company is technically insolvent
Shareholders’ Funds (Equity)	-£160,602	Negative equity indicates accumulated losses and solvency risk
Tangible Fixed Assets (Net Book Value)	£72,112	Small asset base; limited collateral value
Employee Count	34	Moderate size; payroll likely a significant ongoing expense

---

3. Diagnosis: Financial Symptoms and Underlying Health

• Liquidity Distress: The company’s cash reserves (£176,522) are insufficient to cover the current liabilities (£1.53M). This “dry throat” symptom suggests the company may struggle to meet short-term obligations promptly.

• Working Capital Deficit: Negative net current assets (-£232,614) indicate the company’s short-term liabilities exceed its short-term assets, a classic sign of financial strain and potential operational disruption.

• Solvency Concerns: Negative shareholders’ funds (-£160,602) and total assets less current liabilities (-£160,502) reveal the company’s liabilities outweigh assets. This “heart weakness” symptom implies the company is technically insolvent on a balance sheet basis, which can undermine creditor confidence.

• Inventory Build-Up: High stock levels (£742,001) relative to cash and receivables suggest possible overstocking or slow-moving inventory. This “clogged arteries” symptom may tie up cash unnecessarily and increase risks of write-downs.

• Stable but Modest Asset Base: Tangible fixed assets are low (£72,112), limiting the company’s ability to leverage physical assets for financing or operational scaling.

• Operational Scale: With 34 employees, the business has a moderate cost base; managing payroll and overheads is critical given the liquidity constraints.

• No Auditor’s Report or Profit & Loss Data: The absence of an income statement limits visibility into profitability and operational cash flow generation, which would offer further diagnostic insight.

---

4. Recommendations: Prescriptions for Financial Wellness

• Improve Liquidity and Cash Flow Management

  • Accelerate debtor collections through tighter credit control and incentives.
  • Review and reduce inventory levels to free up cash—implement just-in-time or demand-driven stock management.
  • Negotiate extended payment terms with suppliers to alleviate immediate cash pressure.

• Address Working Capital Deficit

  • Consider short-term financing options such as overdrafts or invoice financing to bridge cash flow gaps.
  • Explore asset-based lending using tangible assets if feasible.

• Restructure Debt Obligations

  • Engage creditors early to negotiate restructuring, potentially converting short-term liabilities to longer-term arrangements.
  • Avoid penalties or insolvency risks by maintaining open communication.

• Enhance Operational Efficiency

  • Review cost structures, especially payroll and overheads, to align with cash flow realities.
  • Investigate profitability drivers once income data is available to focus on high-margin products.

• Strengthen Financial Reporting

  • Prepare and review full audited accounts including profit and loss to monitor trends.
  • Implement regular cash flow forecasting and financial health monitoring.

• Consider Strategic Options

  • If the negative equity trend continues, evaluate capital injections or equity financing to bolster net assets.
  • Analyze market position and business model viability to determine if turnaround or divestment is appropriate.

---

Executive Summary

AW Aromatics Limited is currently experiencing financial distress characterized by negative working capital and shareholders’ funds, signaling liquidity and solvency challenges. The company’s high inventory and short-term liabilities exacerbate cash flow pressures, calling for urgent action to improve liquidity management, renegotiate debts, and optimize operations to restore financial health. Without prompt intervention, these symptoms may worsen, threatening the company’s ongoing viability.